MØLLER, Søren; GRUNNET, Kirsten; HANSEN, Steinbjørn; SCHULT, Henrik; HOLMBERG, Mats; SORENSEN, Morten. A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy. Acta Oncologica, [S. l.], v. 51, n. 6, p. 797–804, 2012. DOI: 10.3109/0284186X.2012.681063. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/31585. Acesso em: 15 may. 2026.